Search ( Ctrl + / )

Edwards Lifesciences Corp

EWNYSE

$78.35

+0.43

0.55%

Last Updated: Aug 8, 20:00

EW Financials

Search ( Ctrl + / )

Edwards Lifesciences Corp

EWNYSE

$78.35

+0.43

0.55%

Last Updated: Aug 8, 20:00

EW Financials

	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Statement Date	6/30/2025	3/31/2025	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023
Revenue	1.53B	1.41B	1.35B	1.39B	1.60B	1.53B	1.48B	1.53B
Cost of Revenue	342.60M	301.60M	262.90M	297.80M	384.20M	356.90M	350.40M	343.00M
Gross Profit	1.19B	1.11B	1.09B	1.09B	1.21B	1.18B	1.13B	1.19B
Gross Profit Ratio	0.78	0.79	0.81	0.79	0.76	0.77	0.76	0.78
Research and Development Expenses	276.20M	254.60M	253.40M	272.60M	285.20M	270.00M	270.30M	270.30M
General and Administrative Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling and Marketing Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Expenses	-19.50M	-4.00M	23.70M	2.00M	-1.40M	-6.20M	5.80M	2.20M
Operating Expenses	758.70M	716.30M	698.50M	723.40M	776.30M	748.80M	709.90M	739.00M
Cost and Expenses	1.10B	1.01B	960.10M	1.02B	1.16B	1.11B	1.06B	1.08B
Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation and Amortization	0.00	36.60M	34.50M	39.60M	38.50M	36.70M	4.40M	-1.60M
EBITDA	400.20M	470.50M	428.80M	416.80M	398.50M	368.30M	422.80M	569.20M
EBITDA Ratio	0.26	0.33	0.32	0.29	0.33	0.24	0.29	0.37
Operating Income	430.90M	394.80M	394.30M	364.70M	437.70M	400.10M	418.40M	327.20M
Operating Income Ratio	0.28	0.28	0.29	0.26	0.27	0.26	0.28	0.21
Total Other Income Expenses	-30.70M	39.10M	8.50M	17.50M	-28.30M	-23.50M	3.60M	-118.80M
Income Before Tax	400.20M	433.90M	402.80M	386.60M	409.40M	421.70M	439.30M	338.50M
Income Before Tax Ratio	0.26	0.31	0.30	0.28	0.26	0.27	0.30	0.22
Income Tax Expense	64.30M	70.30M	40.70M	20.20M	58.40M	52.00M	55.60M	33.00M
Net Income	333.20M	358.00M	3.07B	366.30M	351.90M	369.90M	384.90M	307.10M
Net Income Ratio	0.22	0.25	2.27	0.26	0.22	0.24	0.26	0.20
EPS	0.57	0.61	5.14	0.61	0.58	0.61	0.63	0.51

	Q2 2025	Q1 2025	Q3 2024	Q2 2024	Q1 2024	Q4 2023	Q3 2023	Q2 2023
Statement Date	6/30/2025	3/31/2025	9/30/2024	6/30/2024	3/31/2024	12/31/2023	9/30/2023	6/30/2023
Revenue	1.53B	1.41B	1.35B	1.39B	1.60B	1.53B	1.48B	1.53B
Cost of Revenue	342.60M	301.60M	262.90M	297.80M	384.20M	356.90M	350.40M	343.00M
Gross Profit	1.19B	1.11B	1.09B	1.09B	1.21B	1.18B	1.13B	1.19B
Gross Profit Ratio	0.78	0.79	0.81	0.79	0.76	0.77	0.76	0.78
Research and Development Expenses	276.20M	254.60M	253.40M	272.60M	285.20M	270.00M	270.30M	270.30M
General and Administrative Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Selling and Marketing Expenses	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Other Expenses	-19.50M	-4.00M	23.70M	2.00M	-1.40M	-6.20M	5.80M	2.20M
Operating Expenses	758.70M	716.30M	698.50M	723.40M	776.30M	748.80M	709.90M	739.00M
Cost and Expenses	1.10B	1.01B	960.10M	1.02B	1.16B	1.11B	1.06B	1.08B
Interest Expense	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
Depreciation and Amortization	0.00	36.60M	34.50M	39.60M	38.50M	36.70M	4.40M	-1.60M
EBITDA	400.20M	470.50M	428.80M	416.80M	398.50M	368.30M	422.80M	569.20M
EBITDA Ratio	0.26	0.33	0.32	0.29	0.33	0.24	0.29	0.37
Operating Income	430.90M	394.80M	394.30M	364.70M	437.70M	400.10M	418.40M	327.20M
Operating Income Ratio	0.28	0.28	0.29	0.26	0.27	0.26	0.28	0.21
Total Other Income Expenses	-30.70M	39.10M	8.50M	17.50M	-28.30M	-23.50M	3.60M	-118.80M
Income Before Tax	400.20M	433.90M	402.80M	386.60M	409.40M	421.70M	439.30M	338.50M
Income Before Tax Ratio	0.26	0.31	0.30	0.28	0.26	0.27	0.30	0.22
Income Tax Expense	64.30M	70.30M	40.70M	20.20M	58.40M	52.00M	55.60M	33.00M
Net Income	333.20M	358.00M	3.07B	366.30M	351.90M	369.90M	384.90M	307.10M
Net Income Ratio	0.22	0.25	2.27	0.26	0.22	0.24	0.26	0.20
EPS	0.57	0.61	5.14	0.61	0.58	0.61	0.63	0.51